Healthcare - Press Releases

  • 1045 Press Releases ยท
  • RSS
Published on Tue 18 Mar 2025 13:14:35 UTC
AMES, Iowa, March 18, 2025 /PRNewswire/ --GlobalVetLink (GVL), the leader in digital animal health compliance solutions, has announced a new integration with Provet Cloud, a leading cloud-based veterinary practice management system. This integration streamlines the creation of health certificates and other regulatory compliance documents, reducing administrative burdens and enhancing efficiency for veterinary professionals.
Published on Tue 18 Mar 2025 13:14:31 UTC
UNITY is the only commercially available non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a single maternal blood draw.
Published on Tue 18 Mar 2025 13:14:26 UTC
With the introduction of DSai (Digital Sign-In with AI), Groupize gives Life Sciences companies an innovative new technology designed to streamline and digitize attendee management while ensuring compliance and accuracy.
Published on Tue 18 Mar 2025 13:12:00 UTC
Turpaz sales in the fourth quarter jumped 65% to a record $55 million; adj. EBITDA, which is among the industry leaders, rose to 23% of sales in the fourth quarter, reflecting a 66.7% increase compared to the corresponding quarter; operating profit in the fourth quarter jumped 71% and net profit grew 34.5%
Published on Tue 18 Mar 2025 13:11:06 UTC
Hamilton Spence Is Among Few Neonatologists Awarded This Specialized Designation
Published on Tue 18 Mar 2025 13:10:24 UTC
CHAPEL HILL, N.C., March 18, 2025 /PRNewswire/ -- SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomySystem for venous thromboembolism (VTE), a novel treatment solution intended to provide better outcomes for millions of patients suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE), has successfully completed an initial set of eight cases in patients with DVT in its First-In-Human (FIH) study.
Published on Tue 18 Mar 2025 13:04:28 UTC
SaaS solution minimizes manual processes, accelerates batch release cycles and meets regulatory compliance*
Published on Mon 17 Mar 2025 12:37:42 UTC
SAN JOSE, Calif., March 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and Chief Executive Officer, Dr. Amit Kumar, will be presenting at the 2025 Cancer Advocacy Group of Louisiana ("CAGLA") NeauxCancer Conference taking place on March 27-29, 2025 at the The Roosevelt Hotel in New Orleans.
Published on Mon 17 Mar 2025 12:37:37 UTC
Bracco Diagnostics Inc. (PRNewsFoto/Bracco Diagnostics Inc.) (PRNewsfoto/Bracco Group) HeartSee Logo
Published on Mon 17 Mar 2025 12:37:30 UTC
NEW YORK, March 17, 2025 /PRNewswire/ --GRIN Therapeutics, Inc., a leader in the development of therapies to treat serious neurodevelopmental disorders, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug designation for its investigational drug,radiprodil, for the treatment of GRIN-related neurodevelopmental disorder (NDD). Radiprodil is designed as a potent negative allosteric modulator selectively targeting the N-methyl-D-aspartate receptor subtype 2B (NR2B or GluN2B). The company is on track to initiate a pivotal Phase 3 trial for radiprodil in mid-2025 for the treatment of GRIN-related NDD with GoF mutations and has an ongoing global open-label clinical trial of radiprodil for the treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II.
Published on Mon 17 Mar 2025 12:37:28 UTC
Seven abstracts highlight long-term effects, consistent safety profile,and delayed disease progression with givinostat
Published on Mon 17 Mar 2025 12:37:24 UTC
- REDUCE 1 is a study running in parallel with REDUCE 2 to evaluate AR882's efficacy in lowering serum urate (sUA) levels in gout patients -
Published on Mon 17 Mar 2025 12:37:19 UTC
WILMINGTON, Del., March 17, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2024, and provided a business update.
Published on Mon 17 Mar 2025 12:37:16 UTC
CAMBRIDGE, United Kingdom, March 17, 2025 /PRNewswire/ --IgniteData has announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) and Cambridge University Hospitals NHS Foundation Trust (CUH) to launch its Archer tool for clinical data integration in an ongoing Phase 3 study sponsored by AstraZeneca. This collaboration marks a significant milestone in IgniteData's aim of transforming clinical trials through automation and digital innovation.
Published on Mon 17 Mar 2025 12:37:14 UTC
PRODIA SPORT -- ONE BUR. COMPLETE PROCEDURE.
Published on Mon 17 Mar 2025 12:37:08 UTC
SubtleHD sets a new benchmark in image quality and speed for European MRI providers.
Published on Mon 17 Mar 2025 12:36:59 UTC
HAMPTON, N.H., March 17, 2025 /PRNewswire/ -- Planet Fitness, one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, is here to help everyone rebound and recoverfrom the upsets, wins and losses of basketball's biggest games over the next few weeks. March will test your strength, and from now until April 8, new members can sign up for the PF Black Card and get their first month free when they join for just $1 down, $24.99 a month using promo code RR2025. With the PF Black Card, members can bring a guest for free, visit any Planet Fitness location, and take advantage of the Black Card Spathat includes massage chairs, HydroMassage beds, and more. All Planet Fitness memberships offer best-in-class strength and cardio equipment, free fitness training, and many locations are open 24 hours. Find the nearest club or join online here.
Published on Mon 17 Mar 2025 12:36:29 UTC
NEW YORK, March 17, 2025 /PRNewswire/ -- Angels On Call Homecare proudly announces its recognition as a Community Partner in Parkinson's Care by the Parkinson's Foundation. This prestigious membership program enhances the quality of care for individuals with Parkinson's disease (PD). This partnership underscores Angels On Call's commitment to providing specialized, compassionate care that empowers clients to live with dignity and purpose.
Published on Mon 17 Mar 2025 12:35:21 UTC
SHANGHAI, March 17, 2025 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and life sciencesindustry, today announced financial results for the year ending December 31, 2024 ("Reporting Period"):
Published on Mon 17 Mar 2025 12:34:57 UTC
Volition to host multiple presentations at the International Symposium on Intensive Care & Emergency Medicine in Brussels, Belgium, from March 18 - 21
Published on Mon 17 Mar 2025 12:34:55 UTC
DarioHealth expands its payer network with a new regional health plan, an affiliate of one of the top 10 national health plans, bolstering recurring revenue growth and reinforcing its position in one of healthcare's fastest-growing sectors; Dario's AI-driven digital health platform continues to drive adoption among payers seeking scalable, data-driven solutions
Published on Mon 17 Mar 2025 12:34:51 UTC
NEW YORK, March 17, 2025 /PRNewswire/ --Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition with its revolutionary in-development product, the "AI Tumor Ablation Surgical Robot."This prestigious recognition marks a significant milestone in the advancement of AI and robotics integrationthat Baird Medical is developing in the medical field.
Published on Mon 17 Mar 2025 12:34:47 UTC
SAN DIEGO, March 17, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with once-daily INGREZZA (valbenazine) capsules in adults with Huntington's disease. The post-hoc analysis was presented at the Neuroscience Advanced Practice ProviderSymposium hosted by the American Association of Neuroscience Nurses in New Orleans.
Published on Mon 17 Mar 2025 12:34:35 UTC
U.S. Dermatology Partners expands access to dermatology care in Young County with the opening of this new office.